We are live on ! Find out more
VKTX icon

Viking Therapeutics

410 hedge funds and large institutions have $2.43B invested in Viking Therapeutics in 2026 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 156 increasing their positions, 117 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

239% more call options, than puts

Call options by funds: $241M | Put options by funds: $71M

33% more repeat investments, than reductions

Existing positions increased: 156 | Existing positions reduced: 117

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

0.3% less ownership

Funds ownership: 63.64%63.34% (-0.3%)

4% less capital invested

Capital invested by funds: $2.53B → $2.43B (-$108M)

4% less first-time investments, than exits

New positions opened: 66 | Existing positions closed: 69

3% less funds holding

Funds holding: 424410 (-14)

Holders
410
Holders Change
-14
Holders Change %
-3.3%
% of All Funds
5.05%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
66
Increased
156
Reduced
117
Closed
69
Calls
$241M
Puts
$71M
Net Calls
+$170M
Net Calls Change
-$57.9M
Name Holding Trade Value Shares
Change
Change in
Stake
TPWA
401
Twin Peaks Wealth Advisors
California
$325 +$321 +10 New
RIL
402
Rothschild Investment LLC
Illinois
$260 +$225 +7 +700%
GWP
403
Gen-Wealth Partners
Michigan
$228
AWM
404
Abound Wealth Management
Tennessee
$196 +$193 +6 New
TFA
405
Transamerica Financial Advisors
Florida
$195 +$32 +1 +20%
HFS
406
Hughes Financial Services
Virginia
$163 +$96 +3 +150%
MA
407
MCF Advisors
Kentucky
$131 +$129 +4 New
BHWM
408
Beaird Harris Wealth Management
Texas
$90
DF
409
Dunhill Financial
United Kingdom
$52 -$3.25K -101 -99%
Two Sigma Advisers
410
Two Sigma Advisers
New York
-$74.9M -2,129,228 Closed
Point72 Asset Management
411
Point72 Asset Management
Connecticut
-$10.1M -313,492 Closed
Verition Fund Management
412
Verition Fund Management
Connecticut
-$3.97M -112,737 Closed
ACM
413
Aquatic Capital Management
Illinois
-$3.32M -94,275 Closed
SFM
414
Soros Fund Management
New York
-$3.17M -90,000 Closed
SCM
415
Soleus Capital Management
Connecticut
-$2.46M -70,000 Closed
BG
416
Bellevue Group
Switzerland
-$2.42M -68,665 Closed
SSA
417
Schonfeld Strategic Advisors
New York
-$2.38M -67,647 Closed
DFCM
418
Dark Forest Capital Management
Puerto Rico
-$1.67M -47,423 Closed
LIA
419
Limestone Investment Advisors
New York
-$1.52M -43,207 Closed
MWM
420
Meadowbrook Wealth Management
New York
-$1.31M -37,205 Closed
CM
421
Caption Management
Oklahoma
-$1.19M -36,880 Closed
AIMCA
422
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$1.24M -35,300 Closed
Nomura Holdings
423
Nomura Holdings
Japan
-$1.06M -30,000 Closed
CCM
424
Cinctive Capital Management
New York
-$980K -27,860 Closed
WG
425
Winton Group
United Kingdom
-$836K -23,762 Closed

VKTX Hedge Fund Activity: Q1 2026 in Review

410 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2026, worth a combined $2.43B — down 4.3% from $2.53B a quarter earlier.

Sellers outnumbered buyers: 69 funds closed out of VKTX and 66 opened new positions — a net loss of 3 holders — while 117 trimmed existing stakes and 156 added.

The largest buyer was Two Sigma Investments, adding an estimated $64.2M. The largest seller was Jane Street, cutting an estimated $24.2M.

  • 410 institutional investors held Viking Therapeutics (VKTX) as of Q1 2026, down from 424 in Q4 2025.
  • Funds reported $2.43B of Viking Therapeutics stock for Q1 2026, down 4.3% quarter-over-quarter.
  • 66 funds opened new Viking Therapeutics positions in Q1 2026 and 69 closed out, a net change of -3 holders.
  • The largest Viking Therapeutics buyer in Q1 2026 was Two Sigma Investments, an estimated $64.2M added.
  • The largest Viking Therapeutics seller in Q1 2026 was Jane Street, an estimated $24.2M sold.

Based on aggregated 13F filings for Q1 2026.